Implications of Heterogeneity of Epithelial-Mesenchymal States in Acromegaly Therapeutic Pharmacolog...
Implications of Heterogeneity of Epithelial-Mesenchymal States in Acromegaly Therapeutic Pharmacologic Response
About this item
Full title
Author / Creator
Gil, Joan , Marques-Pamies, Montserrat , Valassi, Elena , García-Martínez, Araceli , Serra, Guillermo , Hostalot, Cristina , Fajardo-Montañana, Carmen , Carrato, Cristina , Bernabeu, Ignacio , Marazuela, Mónica , Rodríguez-Lloveras, Helena , Cámara, Rosa , Salinas, Isabel , Lamas, Cristina , Biagetti, Betina , Simó-Servat, Andreu , Webb, Susan M. , Picó, Antonio , Jordà, Mireia and Puig-Domingo, Manel
Publisher
Switzerland: MDPI AG
Journal title
Language
English
Formats
Publication information
Publisher
Switzerland: MDPI AG
Subjects
More information
Scope and Contents
Contents
Acromegaly is caused by excess growth hormone (GH) produced by a pituitary tumor. First-generation somatostatin receptor ligands (SRLs) are the first-line treatment. Several studies have linked E-cadherin loss and epithelial-mesenchymal transition (EMT) with resistance to SRLs. Our aim was to study EMT and its relationship with SRLs resistance in G...
Alternative Titles
Full title
Implications of Heterogeneity of Epithelial-Mesenchymal States in Acromegaly Therapeutic Pharmacologic Response
Authors, Artists and Contributors
Author / Creator
Marques-Pamies, Montserrat
Valassi, Elena
García-Martínez, Araceli
Serra, Guillermo
Hostalot, Cristina
Fajardo-Montañana, Carmen
Carrato, Cristina
Bernabeu, Ignacio
Marazuela, Mónica
Rodríguez-Lloveras, Helena
Cámara, Rosa
Salinas, Isabel
Lamas, Cristina
Biagetti, Betina
Simó-Servat, Andreu
Webb, Susan M.
Picó, Antonio
Jordà, Mireia
Puig-Domingo, Manel
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_4eaadb6f99aa4534893da681de8f25c9
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_4eaadb6f99aa4534893da681de8f25c9
Other Identifiers
ISSN
2227-9059
E-ISSN
2227-9059
DOI
10.3390/biomedicines10020460
